Predicting outcomes after mitral valve repair
Part of Heart & circulation clinical trials.
This study looks at how well a newer, less invasive heart valve repair works for people with leaky mitral valves. It aims to create a tool to predict who will get the best results.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are having a procedure called transcatheter mitral valve edge-to-edge repair (TEER) while in the hospital.
- You are 18 years old or older.
- You are able to sign a consent form agreeing to be in the study.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a minimally invasive procedure (transcatheter edge-to-edge repair) to fix a leaky mitral valve caused by an enlarged atrium, not by heart muscle damage. It might be an option if your mitral regurgitation is related to atrial issues and your heart's pumping strength is normal.
This study looks at whether using a special heart ultrasound during surgery (called RT3D-TEE) can lead to better results for people having mitral valve repair. It’s mainly for certain types of chronic mitral valve leakage.
This study is gathering information from people getting a less invasive procedure called M-TEER to fix a leaky mitral valve. Joining helps doctors learn more about how this treatment works in real life.
This registry study follows people who are getting a minimally invasive heart valve repair called M-TEER. It helps doctors learn more about how well the procedure works and how patients recover.
This trial compares a less invasive catheter procedure to the standard surgical operation to treat “secondary” leaking of the mitral valve. It may help people with significant valve leak decide which approach works better for reducing symptoms and heart strain.
This trial tests a catheter-based procedure to repair a leaking mitral valve in people who are in severe heart shock and need medication support. The goal is to reduce the valve leak and see if it helps patients stabilize and recover.
Hear when a new Mitral Insufficiency trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.